JP2015504426A5 - - Google Patents

Download PDF

Info

Publication number
JP2015504426A5
JP2015504426A5 JP2014541379A JP2014541379A JP2015504426A5 JP 2015504426 A5 JP2015504426 A5 JP 2015504426A5 JP 2014541379 A JP2014541379 A JP 2014541379A JP 2014541379 A JP2014541379 A JP 2014541379A JP 2015504426 A5 JP2015504426 A5 JP 2015504426A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
hydrogen
aryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014541379A
Other languages
English (en)
Japanese (ja)
Other versions
JP6072058B2 (ja
JP2015504426A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/064706 external-priority patent/WO2013074459A1/en
Publication of JP2015504426A publication Critical patent/JP2015504426A/ja
Publication of JP2015504426A5 publication Critical patent/JP2015504426A5/ja
Application granted granted Critical
Publication of JP6072058B2 publication Critical patent/JP6072058B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014541379A 2011-11-14 2012-11-12 顆粒球コロニー刺激因子受容体と結合する方法および組成物 Active JP6072058B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161559660P 2011-11-14 2011-11-14
US61/559,660 2011-11-14
US201161561510P 2011-11-18 2011-11-18
US61/561,510 2011-11-18
PCT/US2012/064706 WO2013074459A1 (en) 2011-11-14 2012-11-12 Methods and compositions associated with the granulocyte colony-stimulating factor receptor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016253294A Division JP2017095481A (ja) 2011-11-14 2016-12-27 顆粒球コロニー刺激因子受容体と結合する方法および組成物

Publications (3)

Publication Number Publication Date
JP2015504426A JP2015504426A (ja) 2015-02-12
JP2015504426A5 true JP2015504426A5 (https=) 2015-12-24
JP6072058B2 JP6072058B2 (ja) 2017-02-01

Family

ID=47258112

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014541379A Active JP6072058B2 (ja) 2011-11-14 2012-11-12 顆粒球コロニー刺激因子受容体と結合する方法および組成物
JP2016253294A Pending JP2017095481A (ja) 2011-11-14 2016-12-27 顆粒球コロニー刺激因子受容体と結合する方法および組成物
JP2018106998A Pending JP2018150369A (ja) 2011-11-14 2018-06-04 顆粒球コロニー刺激因子受容体と結合する方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016253294A Pending JP2017095481A (ja) 2011-11-14 2016-12-27 顆粒球コロニー刺激因子受容体と結合する方法および組成物
JP2018106998A Pending JP2018150369A (ja) 2011-11-14 2018-06-04 顆粒球コロニー刺激因子受容体と結合する方法および組成物

Country Status (5)

Country Link
US (4) US9492430B2 (https=)
EP (1) EP2780322B1 (https=)
JP (3) JP6072058B2 (https=)
CN (2) CN109293551A (https=)
WO (1) WO2013074459A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013074459A1 (en) * 2011-11-14 2013-05-23 Ligand Pharmaceuticals, Inc. Methods and compositions associated with the granulocyte colony-stimulating factor receptor
US9962370B2 (en) 2013-03-15 2018-05-08 Ligand Pharmaceuticals Incorporated Methods of treatment associated with the granulocyte colony-stimulating factor receptor
WO2020070332A1 (en) * 2018-10-05 2020-04-09 Ichnos Sciences S.A. Oxindole compounds for use as map4k1 inhibitors

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19816624A1 (de) 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
CN1376150A (zh) * 1999-07-26 2002-10-23 盐野义制药株式会社 具有血栓形成素受体拮抗作用的药物组合物
CY2010012I2 (el) 2000-05-25 2020-05-29 Novartis Ag Μιμητικα θρομβοποιητινης
JP2002167378A (ja) * 2000-09-22 2002-06-11 Ss Pharmaceut Co Ltd イミダゾール誘導体又はその塩
ATE384076T1 (de) * 2000-12-21 2008-02-15 Smithkline Beecham Corp Regulierte aktivierung von zellmembranrezeptoren durch metallchelatisierende agonisten
WO2003011287A1 (en) * 2001-08-03 2003-02-13 Vertex Pharmaceuticals Incorporated Pyrazolon derivatives as inhibitors of gsk-3
GB0126036D0 (en) 2001-10-30 2001-12-19 Amedis Pharm Ltd Silicon compounds
WO2003103686A1 (en) 2002-06-06 2003-12-18 Smithkline Beecham Corporation Thrombopoietin mimetics
TWI324593B (en) 2002-10-09 2010-05-11 Nissan Chemical Ind Ltd Pyrazolone compounds and thrombopoietin receptor activator
EP1622609A4 (en) * 2003-04-29 2008-09-03 Smithkline Beecham Corp METHODS OF TREATING DEGENERATIVE DISEASES / LESIONS
MXPA06000441A (es) 2003-07-17 2006-04-05 Astellas Pharma Inc Derivado de 2-acilaminotiazole o sal del mismo.
KR100776961B1 (ko) 2003-08-12 2007-11-28 시오노기세이야쿠가부시키가이샤 트롬보포이에틴 수용체 아고니스트 작용을 가지는 화합물
JP2007528423A (ja) * 2004-03-11 2007-10-11 セコイア、ファーマシューティカルズ、インコーポレイテッド 耐性防止レトロウイルスプロテアーゼ阻害薬
DE102004012068A1 (de) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
WO2005094805A1 (ja) * 2004-04-01 2005-10-13 Institute Of Medicinal Molecular Design. Inc. イミン誘導体及びアミド誘導体
JP2005305836A (ja) * 2004-04-21 2005-11-04 Tdk Corp 光記録材料及び光記録媒体
WO2005118551A2 (en) * 2004-05-28 2005-12-15 Ligand Pharmaceuticals Inc. Thrombopoietin activity modulating compounds and methods
MX2007003377A (es) 2004-09-23 2007-05-10 Pfizer Prod Inc Agonistas del receptor de trombopoyetina.
CA2583764C (en) 2004-10-25 2009-06-09 Ligand Pharmaceuticals, Inc. Thrombopoietin activity modulating compounds and methods
WO2007004038A1 (en) 2005-07-05 2007-01-11 Pfizer Products Inc. Aminothiazole derivatives as agonists of the thrombopoietin receptor
WO2007036769A1 (en) 2005-07-05 2007-04-05 Pfizer Products Inc. Aminothiazole derivatives as agonists of the thrombopoietin receptor
WO2007008529A2 (en) * 2005-07-08 2007-01-18 Kalypsys, Inc Celullar cholesterol absorption modifiers
JP2007063443A (ja) * 2005-08-31 2007-03-15 Tdk Corp 錯化合物及びこれを用いた光記録媒体
FR2890987B1 (fr) * 2005-09-19 2007-10-26 Seb Sa Fer a repasser comportant un dispositif guide cordon perfectionne.
WO2007054783A2 (en) 2005-11-08 2007-05-18 Astellas Pharma Inc. Compositions and methods for treating thrombocytopenia
CA2630234A1 (en) * 2005-11-23 2007-05-31 Ligand Pharmaceuticals Inc. Thrombopoietin activity modulating compounds and methods
JP4939078B2 (ja) * 2006-02-24 2012-05-23 キヤノン株式会社 現像ローラ、プロセスカートリッジ、電子写真装置
MX2008011666A (es) 2006-03-15 2008-10-17 Ligand Pharm Inc Sintesis de compuestos que modulan la actividad de la trombopoyetina.
JP5157900B2 (ja) 2006-06-07 2013-03-06 日産化学工業株式会社 含窒素ヘテロ環化合物及びトロンボポエチンレセプター活性化剤
CA2670345A1 (en) * 2006-12-01 2008-06-12 Stategics, Inc. Thrombopoietin mimetics
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
CN101514179A (zh) 2008-02-21 2009-08-26 上海恒瑞医药有限公司 吲哚酮亚乙基肼羰基化合物、其制备方法及其在医药上的应用
US8263642B2 (en) * 2008-06-25 2012-09-11 Vanderbilt University Antimicrobial compounds and methods of use thereof
WO2013074459A1 (en) * 2011-11-14 2013-05-23 Ligand Pharmaceuticals, Inc. Methods and compositions associated with the granulocyte colony-stimulating factor receptor

Similar Documents

Publication Publication Date Title
JP2013507446A5 (https=)
KR102093608B1 (ko) 이미다조피리딘 화합물
JP2020502092A5 (https=)
JP2013543842A5 (https=)
JP2013544261A5 (https=)
JP2015508092A5 (https=)
JP2017533968A5 (https=)
JP2010524932A5 (https=)
JP2008195730A5 (https=)
JP2014510727A5 (https=)
JP2008513498A5 (https=)
JP2012504608A5 (https=)
UA102679C2 (ru) Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии
JP2014502266A5 (https=)
JP2015535832A5 (https=)
JP2013502430A5 (https=)
JP2016535732A5 (https=)
JP2013514980A5 (https=)
JP2010500293A5 (https=)
JP2014506599A5 (https=)
RU2017123114A (ru) 3-оксо-3-(ариламино)пропионаты, способ их получения и их применение в получении пирролидинонов
JP2014525432A5 (https=)
JP2013510178A5 (https=)
JP2010504286A5 (https=)
JP2011517453A5 (https=)